Rapid diagnosis of Long QT syndrome protects family from major health risk
Congenica supports the rapid diagnosis of Long QT syndrome and enables consideration of potentially life-saving interventions for baby and mother.
Raising awareness of Dravet Syndrome
Galia Wilson and Claire Eldred have provided us with today's article in recognition of International Dravet Syndrome Awareness day, Wednesday 23rd June.
Our story of Norrie Disease
We welcome guest blogger Carla Golledge, who shares her story about son Cameron who was born with Norrie disease.
The challenges and opportunities for growth during a global pandemic
Congenica's Chairman Andy Richards and CEO David Atkins join leaders from biotech / pharma sector to discuss the impact of pandemic in the last 18 months.
Enhanced whole exome analysis enables Veritas Intercontinental to solve more cases
Veritas Genetics partnered with Congenica to improve diagnostic yield & increase the efficiency, throughput and speed of analysis in diagnostic laboratory
Mutual Collaboration focus for CRDN Companies Forum
Alastair Kent and Dr Charles Steward attended the virtual Cambridge Rare Disease Network (CRDN) Companies Forum Patient Group and Industry Partnering event
Helping to Further the Patient Impact of Genomics
Dr Charles Steward was interviewed for podcast, Once Upon a Gene, where Effie speaks to others about their journey through life with rare disease.
How Schinzel-Giedion Syndrome (SGS) has changed our lives
Nuala Summerfield tells the story of her daughter's diagnosis of rare disease Schinzel-Giedion Syndrome (SGS) and setting up The SGS Foundation
Dr Charles Steward joins as “friend” of the UK Infantile Spasms Trust
Congenica's Dr Charles Steward joins the “friends” of the UK infantile Spasms Trust as an advocate and advisor
Improved Next Generation Sequencing for Ultrasound Abnormalities (INGENIOUS)
At the Curating the Clinical Genome event in May 2021, Suzanne Drury, Lead Transitional Scientist, Prenatal Genomics and Personalized Health at Congenica presented a poster that detailed ...
Our CHAMP1 journey
A father's story of having a son with a disease so rare that he is only one of 38 kids in the world to be diagnosed with Champ1, and what it means.
Dr Charles Steward elected to the ICPGC GC
Congenica’s Patient Advocacy and Engagement lead, Dr Charles Steward, has joined the International Cerebral Palsy Genome Consortium Governance Council.